Watch VideoThe Trump administration has reached a deal with biotechnology company Moderna to purchase 100 million doses of its experimental coronavirus vaccine.
The vaccine, which was also developed by the National Institutes of Health, is currently in late-stage human trials.
Unlike most vaccines, which introduce a...
U.S. Agrees To Buy 100 Million Doses Of Another COVID-19 Vaccine
Newsy
0 shares
1 views
You might like
Related news coverage
Canada strikes more deals for COVID-19 vaccine, but may have to wait in line behind other nations
National Post
Capping a flurry of procurement announcements Monday, the federal government made a bold claim: Canada would be at the “front of..
-
U.S. drug company Novavax signs deal to supply 76 million doses of possible COVID-19 vaccine to Canada
CBC.ca
-
U.S. drug company Novavax signs deal to supply 76M doses of possible COVID-19 vaccine to Canada
CBC.ca
-
Feds sign deal with Novavax to secure up to 76M doses of vaccine candidate
CTV News
-
European Union offers 400 million euros to WHO-led Covid-19 vaccine initiative
Khaleej Times
Advertisement
More coverage
Operation Warp Speed More Than Halfway To Enrolling Participants In Vaccine Trials
Eurasia Review
By C. Todd Lopez
Two of the six candidate vaccines for COVID-19 are now in Phase III trials. Each of those trials will..
-
Germany Says It Could Have Two COVID-19 Vaccines Next Year
Newsy
-
Moderna in Talks to Sell 40 Million Coronavirus Vaccine Doses to Japan
Motley Fool
-
Health care workers prepare for possible 'twindemic' this fall — a double whammy of COVID-19 and flu
National Post
-
Half a billion doses of COVID vaccine - This is how Japan is preparing for Tokyo Olympics
DNA